Multiple Sclerosis Clinical Trials in Houston, TX

13 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Study of COYA 302 for the Treatment of ALS	Phase 2	Coya Therapeutics	<1 mi
TSC Biosample Repository and Natural History Database	—	National Tuberous Sclerosis Association	<1 mi
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS	N/A	The Methodist Hospital Research Institute	<1 mi
Multiple Sclerosis Implementation Network (Registry)	—	The University of Texas Health Science Center, Houston	<1 mi
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis	Phase 1	Amylyx Pharmaceuticals Inc.	<1 mi
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis	Phase 4	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	Phase 2	Darcy Krueger	<1 mi
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis	Phase 3	Sanofi	<1 mi
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis	Phase 2	Eli Lilly and Company	<1 mi
Care in Multiple Sclerosis (MS)	—	NYU Langone Health	<1 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)	Phase 3	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	<1 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease	—	TScan Therapeutics, Inc.	7 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.